Hideko Tasaka

736 total citations · 1 hit paper
20 papers, 563 citations indexed

About

Hideko Tasaka is a scholar working on Oncology, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hideko Tasaka has authored 20 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Neurology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hideko Tasaka's work include Neuroblastoma Research and Treatments (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer therapeutics and mechanisms (4 papers). Hideko Tasaka is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer therapeutics and mechanisms (4 papers). Hideko Tasaka collaborates with scholars based in Japan, Canada and United States. Hideko Tasaka's co-authors include Charlotte Tan, David A. Karnofsky, M. Lois Murphy, Kohji Ueda, Keiichi Ikeda, Akira Nakagawara, Jun Okamura, Eiichi Ishii, Akinobu Matsuzaki and Shouichi Ohga and has published in prestigious journals such as Cancer, British Journal of Haematology and Gynecologic Oncology.

In The Last Decade

Hideko Tasaka

19 papers receiving 522 citations

Hit Papers

Daunomycin, an antitumor antibiotic, in the treatment of ... 1967 2026 1986 2006 1967 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemia
    1967 364 citations Charlotte Tan, Hideko Tasaka et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideko Tasaka Japan 10 195 192 170 97 66 20 563
B D Evans New Zealand 11 362 1.9× 68 0.4× 217 1.3× 28 0.3× 115 1.7× 24 728
Masanori Umeda Japan 15 145 0.7× 31 0.2× 275 1.6× 45 0.5× 41 0.6× 59 533
Sophie Rigaudeau France 11 165 0.8× 114 0.6× 125 0.7× 26 0.3× 41 0.6× 22 558
Fabrizio Ganzina Italy 13 360 1.8× 206 1.1× 141 0.8× 15 0.2× 67 1.0× 23 601
Joanna M. Lubieniecka Canada 13 136 0.7× 94 0.5× 272 1.6× 20 0.2× 144 2.2× 22 519
Rashid A. Fawwaz United States 17 100 0.5× 37 0.2× 165 1.0× 26 0.3× 195 3.0× 87 884
Michael E. Ottlinger United States 8 104 0.5× 322 1.7× 189 1.1× 18 0.2× 82 1.2× 10 675
Ashok Panneerselvam United States 16 330 1.7× 44 0.2× 190 1.1× 142 1.5× 201 3.0× 33 678
Bertino United States 11 190 1.0× 17 0.1× 178 1.0× 28 0.3× 90 1.4× 27 520
M López Italy 14 368 1.9× 158 0.8× 150 0.9× 28 0.3× 258 3.9× 33 724

Countries citing papers authored by Hideko Tasaka

Since Specialization
Citations

This map shows the geographic impact of Hideko Tasaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideko Tasaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideko Tasaka more than expected).

Fields of papers citing papers by Hideko Tasaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideko Tasaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideko Tasaka. The network helps show where Hideko Tasaka may publish in the future.

Co-authorship network of co-authors of Hideko Tasaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hideko Tasaka. A scholar is included among the top collaborators of Hideko Tasaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideko Tasaka. Hideko Tasaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuzaki, Akinobu, Jun Okamura, Eiichi Ishii, et al.. (1999). TREATMENT OF STANDARD-RISK ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN: The Results of Protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan. Pediatric Hematology and Oncology. 16(3). 187–199. 6 indexed citations
2.
Matsuzaki, Akinobu, Eiichi Ishii, Jun Okamura, et al.. (1996). Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan. Medical and Pediatric Oncology. 26(1). 10–19. 9 indexed citations
3.
4.
Nakayama, Hideki, Jun Okamura, Shouichi Ohga, et al.. (1995). Herpes zoster in children with bone marrow transplantation: Report from a single institution. Pediatrics International. 37(3). 302–307. 11 indexed citations
5.
Yanai, Fumio, Jun Okamura, Hideko Tasaka, et al.. (1995). An Effective Salvage Regimen with Aclarubicin for Daunorubicin-Resistant Acute Non-Lymphocytic Leukemia in Children. Pediatric Hematology and Oncology. 12(3). 251–258. 1 indexed citations
6.
Suita, Sachiyo, Yoshio Zaizen, Hiroshi Akiyama, et al.. (1994). How to deal with advanced cases of neuroblastoma detected by mass screening: A report from the pediatric oncology study group of the Kyushu area of Japan. Journal of Pediatric Surgery. 29(5). 599–603. 17 indexed citations
7.
Matsuzaki, Akinobu, Takeshi Inamitsu, Toshiaki Watanabe, et al.. (1994). Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis. British Journal of Haematology. 86(4). 887–889. 22 indexed citations
8.
Yamada, Shin‐ichi, Eiichi Ishii, Akira Nakagawara, et al.. (1992). Features and Outcome of Advanced Neuroblastoma with Distant Lymph Node Metastasis. Pediatric Hematology and Oncology. 9(1). 49–56. 9 indexed citations
9.
Yamada, Shin‐ichi, Eiichi Ishii, Toshiro Kuroiwa, et al.. (1992). Growth Retardation in Childhood Leukemia and Lymphoma. Journal of Pediatric Hematology/Oncology. 14(3). 236–240. 4 indexed citations
10.
Ishii, Eiichi, Akinobu Matsuzaki, Jun Okamura, et al.. (1992). Treatment of Langerhans Cell Histiocytosis in Children with Etoposide. American Journal of Clinical Oncology. 15(6). 515–517. 8 indexed citations
11.
Nishida, Makoto, et al.. (1991). Juvenile granulosa cell tumor in association with a high serum inhibin level. Gynecologic Oncology. 40(1). 90–94. 11 indexed citations
12.
Ohshima, Kohichi, et al.. (1991). Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 419(6). 519–522. 8 indexed citations
13.
Hara, Toshiro, Yumi Mizuno, Jun Okamura, et al.. (1990). Acute Leukemia with Normal Platelet Count at Diagnosis. Pediatrics International. 32(5). 515–518. 3 indexed citations
14.
Morio, Tomohiro, et al.. (1989). The increase of non-MHC-restricted cytotoxic cells ( T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome. Clinical Immunology and Immunopathology. 52(2). 279–290. 23 indexed citations
15.
Ikeda, Keiichi, Akira Nakagawara, Hiroshi Akiyama, et al.. (1989). Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen. Journal of Pediatric Surgery. 24(2). 189–193. 21 indexed citations
16.
Nakagawara, Akira, Keiichi Ikeda, & Hideko Tasaka. (1988). Dopaminergic neuroblastoma as a poor prognostic subgroup. Journal of Pediatric Surgery. 23(4). 346–349. 26 indexed citations
17.
Okamura, Jun, et al.. (1987). Superoxide Generation of Leukemic Cells in Children. Journal of Pediatric Hematology/Oncology. 9(1). 11–14. 3 indexed citations
18.
19.
Okamura, Jun, et al.. (1979). Adenosine deaminase (ADA) activity in leukemic cells of children.. PubMed. 42(4). 621–5. 1 indexed citations
20.
Tan, Charlotte, et al.. (1967). Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemia. Cancer. 20(3). 333–353. 364 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B D Evans Breakdown of academic impact, for papers by Masanori Umeda Breakdown of academic impact, for papers by Sophie Rigaudeau Breakdown of academic impact, for papers by Fabrizio Ganzina Breakdown of academic impact, for papers by Joanna M. Lubieniecka Breakdown of academic impact, for papers by Rashid A. Fawwaz Breakdown of academic impact, for papers by Michael E. Ottlinger Breakdown of academic impact, for papers by Ashok Panneerselvam Breakdown of academic impact, for papers by Bertino Breakdown of academic impact, for papers by M López
Rankless by CCL
2026